AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Terrorism speeds vaccines. (Clinical Capsules).
Concerns about bioterrorism have led to stepped-up vaccine development efforts.
A vaccine against Ebola virus is set to begin human clinical trials in the next 6-7 months, and contracts for developing a new anthrax vaccine have been awarded to two companies, according to the National Institute of Allergy and Infectious Diseases.
Crucell, a Dutch biotechnology company, has exclusive rights to sell the Ebola vaccine, which is made with Ebola genes provided by the NIAID. The focus on bioterrorism and on funding of projects to fight bioterrorism has accelerated the vaccine development process, NIALD director Dr. Anthony Fauci reported at a World Medical Association meeting in Washington last month.
- Use of anthrax vaccine in response to terrorism: Supplemental recommendations...
- Newspaper article from: Morbidity and Mortality Weekly Report November 15, 2002 700+ words
...recommendations for using anthrax vaccine in the United States (1...concerns that the current anthrax vaccine supply is limited, ACIP...recommendations on using anthrax vaccine in response to terrorism...
- Efficacy of US Anthrax Vaccine Questioned.
- Newspaper article from: Korea Times (Seoul, Korea) January 5, 2000 700+ words
...say. However, in the case of an anthrax vaccine, manufactured in the U.S. and...at one year intervals. Under the anthrax vaccine implementation program (AVIP) for...about the potency or efficacy of the anthrax vaccine manufactured by Michigan Biologic...
- VaxGen Awarded $80.3 Million NIAID Contract for Advanced Development of Anthrax...
- Press release article from: PR Newswire October 1, 2003 700+ words
...for the advanced development of its anthrax vaccine candidate, rPA102. The 3-year...contract for a national stockpile of anthrax vaccine. (Logo: http://www.newscom...recombinant Protective Antigen (rPA) anthrax vaccine, pending legislation known as Project...
- NIAID to Fund Development of Emergent BioSolutions' Advanced Anthrax Vaccine...
- Press release article from: Business Wire September 30, 2009 700+ words
...development of one of Emergent's advanced anthrax vaccine candidates known as dmPA7909. The...government's needs for an advanced anthrax vaccine such as the potential to confer a...one of Emergent's next generation anthrax vaccine candidates in development," said...
- VaxGen Completes Development Activity in Support of Anthrax Vaccine Partnering...
- Press release article from: PR Newswire May 24, 2007 700+ words
...further development of its recombinant anthrax vaccine and is laying off 20 employees, or...support ongoing efforts to partner its anthrax vaccine program and was based on the Department...procurement of a next-generation anthrax vaccine. (Logo: NewsCom: http://www...
- Citizen Petition Filed Yesterday at the FDA: Anthrax Vaccine Network Supports...
- Press release article from: PR Newswire October 16, 2001 700+ words
...Michigan firm which manufactures the anthrax vaccine. The petition calls for the FDA to...on the drug category placement of anthrax vaccine as Category II (unsafe, ineffective...declare as adulterated all stockpiles of anthrax vaccine adsorbed in the possession of BioPort...
- VaxGen Responds to Media Report Regarding Proposed Congressional Investigation...
- Press release article from: PR Newswire April 6, 2006 700+ words
...investigation into the company's anthrax vaccine contract by Congressman Mike Rogers...investigation of our Project BioShield anthrax vaccine contract, because: -- The Department...contract for 75 million doses of a modern anthrax vaccine to VaxGen was the result of an open...
- Anthrax Vaccine Award Rescheduled to Nov. 5; VaxGen Believes It Is the Only...
- Press release article from: PR Newswire October 15, 2004 700+ words
...million doses of a recombinant anthrax vaccine to the U.S. government...VaxGen has been developing its anthrax vaccine candidate, rPA102, to address...for a modern recombinant anthrax vaccine, based on a single defined...